Expand AUPH Menu
AUPH MENU

Aurinia Pharmaceuticals - Common Shares (AUPH) closed at $15.48 on November 16, 2026, down 1.6% from the previous close, on volume of 855,870 shares (30-day average 843,394).

Key numbers
  • Last close: $15.48 (November 16, 2026)
  • 52-week range: $13.52 to $19.25
  • Market value: $2.1 billion
  • 30-day implied volatility (IV30): 30.2%
  • Option volume: 329 contracts (267 calls, 62 puts); 30-day average 474

Data as of November 16, 2026.

AUPH Stock Summary and Trading Ideas (Aurinia Pharmaceuticals - Common Shares | NASDAQ:AUPH)

Charts for Today's Stock Price and Implied Volatility in Aurinia Pharmaceuticals - Common Shares

16-Nov-2026

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for AUPH by Theoretical Edge and Win Rates

Sentiment

Largest Multi-Leg Option Trades (30 Days)

#DateStrategyLegsContracts

Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 13, 2026. See the largest for 5, 30, 60 and 90 days

Trading Statistics

Key Ratios

Aurinia Pharmaceuticals - Common Shares (AUPH) Frequently Asked Questions

What does Aurinia Pharmaceuticals - Common Shares do?

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

What symbol and exchange does Aurinia Pharmaceuticals - Common Shares shares trade?

Aurinia Pharmaceuticals - Common Shares trades on the NASDAQ stock market under the symbol AUPH.

What is Aurinia Pharmaceuticals - Common Shares stock price doing today?

As of November 16, 2026, AUPH stock price declined to $15.48 with 855,870 million shares trading.

What is Aurinia Pharmaceuticals - Common Shares's Beta?

AUPH has a beta of 0.05, meaning it tends to be less sensitive to market movements. AUPH has a correlation of 0.00 to the broad based SPY ETF.

How much is Aurinia Pharmaceuticals - Common Shares worth?

AUPH has a market cap of $2.07 billion. This is considered a Mid Cap stock.

How much money does Aurinia Pharmaceuticals - Common Shares make?

Last quarter Aurinia Pharmaceuticals - Common Shares reported $84 million in Revenue and $.23 earnings per share. This fell short of revenue expectation by $-627,264 and exceeded earnings estimates by $.01.

What is the highest and lowest price Aurinia Pharmaceuticals - Common Shares traded in the last 3 year period?

In the last 3 years, AUPH traded as high as $19.25 and as low as $4.71.

What are the top ETFs holding Aurinia Pharmaceuticals - Common Shares?

The top ETF exchange traded funds that AUPH belongs to (by Net Assets): IWM, IWO, IBB, VTWO, FESM.

Is Aurinia Pharmaceuticals - Common Shares (AUPH) a good investment?

AUPH has underperformed the market in the last year with a price return of +1.7% while the SPY ETF gained +11.2%. However, in the short term, AUPH had mixed performance relative to the market. It has outperformed in the last 3 months, returning +2.0% vs -4.6% return in SPY. But in the last 2 weeks, AUPH shares have been beat by the market, returning -7.0% compared to an SPY return of -2.1%.

What are the support and resistance levels for Aurinia Pharmaceuticals - Common Shares (AUPH)?

AUPH support price is $15.38 and resistance is $16.08 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AUPH shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes